Literature DB >> 28355102

Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy.

Atul Ranjan1, Swathi V Iyer1, Tomoo Iwakuma1.   

Abstract

Entities:  

Keywords:  A3AR; GPCR; NF-κB; TMIGD3 i1; cAMP; metastasis; osteosarcoma; sphere; tumor suppressor

Mesh:

Substances:

Year:  2017        PMID: 28355102      PMCID: PMC5462082          DOI: 10.1080/15384101.2017.1308153

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  7 in total

1.  Signaling pathway from the human adenosine A(3) receptor expressed in Chinese hamster ovary cells to the extracellular signal-regulated kinase 1/2.

Authors:  Gunnar Schulte; Bertil B Fredholm
Journal:  Mol Pharmacol       Date:  2002-11       Impact factor: 4.436

Review 2.  The A3 adenosine receptor: history and perspectives.

Authors:  Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi; Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Stefania Merighi; Stefania Gessi
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 3.  Osteosarcoma: Current Treatment and a Collaborative Pathway to Success.

Authors:  Michael S Isakoff; Stefan S Bielack; Paul Meltzer; Richard Gorlick
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

4.  An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-kappa B.

Authors:  Pnina Fishman; Sara Bar-Yehuda; Gil Ohana; Faina Barer; Avivit Ochaion; Abigail Erlanger; Lea Madi
Journal:  Oncogene       Date:  2004-04-01       Impact factor: 9.867

Review 5.  Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

Authors:  James J Morrow; Chand Khanna
Journal:  Crit Rev Oncog       Date:  2015

Review 6.  Metastatic potential of tumor-initiating cells in solid tumors.

Authors:  Amit S Adhikari; Neeraj Agarwal; Tomoo Iwakuma
Journal:  Front Biosci (Landmark Ed)       Date:  2011-01-01

7.  Genome-wide RNAi screening identifies TMIGD3 isoform1 as a suppressor of NF-κB and osteosarcoma progression.

Authors:  Swathi V Iyer; Atul Ranjan; Harold K Elias; Alejandro Parrales; Hiromi Sasaki; Badal C Roy; Shahid Umar; Ossama W Tawfik; Tomoo Iwakuma
Journal:  Nat Commun       Date:  2016-11-25       Impact factor: 14.919

  7 in total
  1 in total

1.  Selective A3 Adenosine Receptor Antagonist Radioligand for Human and Rodent Species.

Authors:  R Rama Suresh; Zhan-Guo Gao; Veronica Salmaso; Eric Chen; Ryan G Campbell; Russell B Poe; Theodore E Liston; Kenneth A Jacobson
Journal:  ACS Med Chem Lett       Date:  2022-03-02       Impact factor: 4.632

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.